U.S. investigators exploring whether or not hemp compounds can help combat COVID-19 and its variants suggest that two specific cannabinoid acids could play a role in both prevention and treatment.
Story continues below
This advertisement has not loaded yet, but your article continues below.
Using a mass spectrometry-based screening technique invented at Oregon State University (OSU), a university statement notes that researchers there and at the Oregon Health & Science University discovered “a pair of cannabinoid acids bind to the SARS-CoV-2 spike protein, blocking a critical step in the process the virus uses to infect people.”
The two compounds are cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA), and the spike protein is the same drug target used in
Read full article on The Growth Op
